GlassScriptPhysician profile
Farhan Irshad
NPI 1871775650
$111,436.71
in general payments reported to CMS, 2019-2025
34 companies · $35K in 2025
The $35K reported for 2025 was more than what 98% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37K · 2020: $5,421 · 2021: $2,173 · 2022: $4,133 · 2023: $9,058 · 2024: $19K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $32K · Consulting Fee: $15K · Food and Beverage: $6,652 · Travel and Lodging: $5,233 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,240 · Long Term Medical Supply Or Device Loan: $636 · Honoraria: $25.59 · Education: $21.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $31,900.00 |
| Consulting Fee | $15,322.10 |
| Food and Beverage | $6,651.72 |
| Travel and Lodging | $5,233.20 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,240.00 |
| Long Term Medical Supply Or Device Loan | $636.00 |
| Honoraria | $25.59 |
| Education | $21.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $38,115.05 | 2022-2025 | Miebo, Xiidra, Blink Nutritears |
| Shire North American Group INC | $11,490.49 | 2019 | |
| Alcon Vision LLC | $11,131.36 | 2019-2025 | Argos, Clareon, Ngenuity |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $9,530.12 | 2019-2021 | |
| Allergan, INC. | $7,619.16 | 2019-2022 | |
| Rxsight INC | $7,542.71 | 2022-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Novartis Pharmaceuticals Corporation | $5,215.52 | 2019-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $4,156.19 | 2019-2022 | |
| Alcon Research LLC | $3,890.97 | 2022-2023 | |
| Oyster Point Pharma, INC. | $3,513.79 | 2022-2025 | Tyrvaya, Ryzumvi |
| Glaukos Corporation | $2,214.42 | 2019-2025 | Idosetr |
| Carl Zeiss Meditec USA, INC. | $1,641.71 | 2022 | |
| Biotissue Holdings INC. | $1,614.08 | 2020-2024 | |
| Omeros Corporation | $1,288.10 | 2019-2021 | |
| Abbvie INC. | $605.41 | 2022-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $425.77 | 2019-2024 | Dextenza |
| Harrow Eye, LLC | $198.42 | 2024-2025 | Vevye |
| Sight Sciences, INC. | $195.82 | 2021-2025 | Omni Surgical System |
| Aerie Pharmaceuticals, INC. | $180.68 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $167.78 | 2019 | |
| Sun Pharmaceutical Industries INC. | $133.27 | 2019-2024 | Cequa |
| Optos, INC. | $98.66 | 2021 | |
| Mallinckrodt Hospital Products INC. | $92.99 | 2020 | |
| Dompe US, INC. | $70.33 | 2020-2025 | Oxervate |
| Eyepoint US, INC. | $46.32 | 2019-2021 | |
| Thea Pharma INC. | $45.55 | 2022-2023 | Iyuzeh |
| Tarsus Pharmaceuticals, INC. | $39.69 | 2024 | Xdemvy |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Amgen INC. | $38.10 | 2024-2025 | Uplizna, Tepezza |
| Kala Pharmaceuticals, INC. | $30.22 | 2022 | |
| Tearlab Corp | $21.87 | 2023 | Tearlab Osmolarity System |
| Eyevance Pharmaceuticals LLC | $15.47 | 2019 | |
| New World Medical,INC. | $14.54 | 2024 | Streamline, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Maculogix, INC. | $13.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farhan Irshad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.